Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vaccine confidence: the keys to restoring trust.
Badur S, Ota M, Öztürk S, Adegbola R, Dutta A. Badur S, et al. Hum Vaccin Immunother. 2020 May 3;16(5):1007-1017. doi: 10.1080/21645515.2020.1740559. Epub 2020 Apr 16. Hum Vaccin Immunother. 2020. PMID: 32298198 Free PMC article.
Impact of COVID-19 pandemic on routine immunization.
Ota MOC, Badur S, Romano-Mazzotti L, Friedland LR. Ota MOC, et al. Ann Med. 2021 Dec;53(1):2286-2297. doi: 10.1080/07853890.2021.2009128. Ann Med. 2021. PMID: 34854789 Free PMC article.
Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries.
Marijam A, Schuerman L, Izurieta P, Pereira P, Van Oorschot D, Mehta S, Ota MO, Standaert B. Marijam A, et al. Hum Vaccin Immunother. 2022 Dec 30;18(7):2135916. doi: 10.1080/21645515.2022.2135916. Epub 2022 Dec 12. Hum Vaccin Immunother. 2022. PMID: 36507685 Free PMC article.
Population Attributable Risk of Wheeze in 2-<6-Year-old Children, Following a Respiratory Syncytial Virus Lower Respiratory Tract Infection in The First 2 Years of Life.
Madhi SA, Ceballos A, Cousin L, Domachowske JB, Langley JM, Lu E, Puthanakit T, Rämet M, Tan A, Zaman K, Anspach B, Bueso A, Cinconze E, Colas JA, D'Andrea U, Dieussaert I, Englund JA, Gandhi S, Jose L, Karhusaari H, Kim JH, Klein NP, Laajalahti O, Mithani R, Ota MOC, Pinto M, Silas P, Stoszek SK, Tangsathapornpong A, Teeratakulpisarn J, Virta M, Cohen RA. Madhi SA, et al. Among authors: ota moc. Pediatr Infect Dis J. 2024 Jul 1. doi: 10.1097/INF.0000000000004447. Online ahead of print. Pediatr Infect Dis J. 2024. PMID: 38985986
Measles, mumps, rubella prevention: how can we do better?
Kauffmann F, Heffernan C, Meurice F, Ota MOC, Vetter V, Casabona G. Kauffmann F, et al. Among authors: ota moc. Expert Rev Vaccines. 2021 Jul;20(7):811-826. doi: 10.1080/14760584.2021.1927722. Epub 2021 Jun 7. Expert Rev Vaccines. 2021. PMID: 34096442 Free article. Review.
Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines - A phase II, randomised, observer-blind study in Gambian infants.
Odutola A, Ota MOC, Antonio M, Ogundare EO, Saidu Y, Owiafe PK, Worwui A, Idoko OT, Owolabi O, Kampmann B, Greenwood BM, Alderson M, Traskine M, Swinnen K, Verlant V, Dobbelaere K, Borys D. Odutola A, et al. Among authors: ota moc. Vaccine. 2019 May 1;37(19):2586-2599. doi: 10.1016/j.vaccine.2019.03.033. Epub 2019 Apr 8. Vaccine. 2019. PMID: 30975570 Free article. Clinical Trial.
57 results